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Generalized epilepsy with febrile seizure 
plus (GEFS+) has been described as an 
autosomal dominant inherited epilepsy 
disorder associated with febrile and afebrile 
seizures (Scheffer and Berkovic., 1997). 
Individuals with GEFS+ are characterized 
by febrile seizures in children and continue 
beyond 6 years of age (Escayg et al., 2000). 
The common phenotypes of GEFS+ are 
heterogenous afebrile seizures that may 
include tonic-clonic, myoclonic, atonic and 
absence seizures (Wallace et all., 2001). 
GEFS+ was associated with mutations in 
the neuronal voltage-gated sodium channel 
subunit gene (SCN1A, SCN2A, SCN1B) and 
ligand-gated gamma aminobutyric acid 
receptor  gene (GABRG2, GABRD).
.
Genetic study
Direct sequencing of SCN1A  revealed seven sequence 
variants that associated with GEFS+ (Table 2). A base  
substitution c. 4765 A>G transition in exon 25 of SCN1A       
(Fig 1) was detected in the GEFS+ patient. The amino acid 
translation show the His1586Arg amino acid substitution.
Clinical features
6 clinically GEFS+ patients ( Table 1) with variety of seizure types and neurological deficits 
including global developmental delay, ataxia and behavioural concerns.
Exon/Intron Variant 
nomenclature
Classification Amino acid change
Intron 7 IVS7-21 Noncoding No
Exon 9 c. 1212 A>G Silent No (Val404Val)
Exon 13 c. 2167 T>C Silent No (Val723Val)
Exon 25 c. 4731 T>C Silent No (Thr1574Thr)
Exon 25 c. 4765 A>G Missense Yes (His1586Arg)
Exon 26 c. 5115 A>G Silent No (Leu1705Leu)
Exon 26 c. 5197 A>G Missense Yes (Asn1733Asp)
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To study the clinical presentations and 
to analyze the SCN1A  gene associated 










30 GEFS+ patients were 
recruited in this study
DNA was extracted from patients 
using DNA extraction kit 
26 exons of SCN1A gene were 
amplified  by PCR from genomic DNA
All exons of SCN1A 
gene were screened for 
mutation by dHPLC
DNA sequencing was used 
to confirm each SCN1A 


























FS, GTCS Ataxia, Social anxiety DD, MR, Learning 
difficulty
GEFS+
G11 (F:16Y) FS, GTCS - - GEFS+
G12 (F:15Y) FS, GTCS Social anxiety - GEFS+
G21
(M:13Y)
FS, GTCS Social anxiety MR, Learning  
difficulty
GEFS+
G22 (M:6Y ) FS, GTCS - DD, Learning 
difficulty
GEFS+
Table 1. Clinical features of GEFS+ patients
Key: M, male; F, female; Y, year; FS, febrile sizures; GTCS, generalized tonic clonic seizures; 
MR, mental retardation; DD, developmental delay; ADHD, attention deficit disorder
Table 2. Summary of SCN1A mutations found in the 30 GEFS+ patients
Figure 1. Sequencing traces (forward direction) showing heterozygous in 
c. 4765 A>G transition in exon 25 of SCN1A of the patient’s genomic DNA. 
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